GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CsGalNAcT-1) (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1)
CGAT1_HUMAN Reviewed; 532 AA.
Q8TDX6; B2RBE4; Q6P9G6; Q8IUF9; Q9NSQ7; Q9NUM9;
01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
05-OCT-2010, sequence version 2.
13-FEB-2019, entry version 144.
RecName: Full=Chondroitin sulfate N-acetylgalactosaminyltransferase 1 {ECO:0000305};
Short=CsGalNAcT-1 {ECO:0000305};
EC=2.4.1.174 {ECO:0000269|PubMed:21160489, ECO:0000269|PubMed:27599773};
AltName: Full=Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;
Short=Beta4GalNAcT-1;
Name=CSGALNACT1 {ECO:0000312|HGNC:HGNC:24290};
Synonyms=CHGN, GALNACT1; ORFNames=UNQ656/PRO1287;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, GLYCOSYLATION,
SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANT ASN-193.
TISSUE=Melanoma;
PubMed=11788602; DOI=10.1074/jbc.M111434200;
Uyama T., Kitagawa H., Tamura J., Sugahara K.;
"Molecular cloning and expression of human chondroitin N-
acetylgalactosaminyltransferase: key enzyme for chain initiation and
elongation of chondroitin/dermatan sulfate on the protein linkage
region tetrasaccharide shared by heparin/heparan sulfate.";
J. Biol. Chem. 277:8841-8846(2002).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
AND VARIANT ASN-193.
PubMed=12163485; DOI=10.1074/jbc.M203619200;
Gotoh M., Sato T., Akashima T., Iwasaki H., Kameyama A., Mochizuki H.,
Yada T., Inaba N., Zhang Y., Kikuchi N., Kwon Y.-D., Togayachi A.,
Kudo T., Nishihara S., Watanabe H., Kimata K., Narimatsu H.;
"Enzymatic synthesis of chondroitin with a novel chondroitin sulfate
N-acetylgalactosaminyltransferase that transfers N-acetylgalactosamine
to glucuronic acid in initiation and elongation of chondroitin sulfate
synthesis.";
J. Biol. Chem. 277:38189-38196(2002).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
ASN-193.
PubMed=12975309; DOI=10.1101/gr.1293003;
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
Wood W.I., Godowski P.J., Gray A.M.;
"The secreted protein discovery initiative (SPDI), a large-scale
effort to identify novel human secreted and transmembrane proteins: a
bioinformatics assessment.";
Genome Res. 13:2265-2270(2003).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Placenta, and Thalamus;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16421571; DOI=10.1038/nature04406;
Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
Lander E.S.;
"DNA sequence and analysis of human chromosome 8.";
Nature 439:331-335(2006).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
ASN-193.
TISSUE=Placenta;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 381-532, AND VARIANT
ASN-193.
TISSUE=Melanoma;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[8]
FUNCTION, AND TISSUE SPECIFICITY.
PubMed=12446672; DOI=10.1074/jbc.M208886200;
Sato T., Gotoh M., Kiyohara K., Akashima T., Iwasaki H., Kameyama A.,
Mochizuki H., Yada T., Inaba N., Togayachi A., Kudo T., Asada M.,
Watanabe H., Imamura T., Kimata K., Narimatsu H.;
"Differential roles of two N-acetylgalactosaminyltransferases,
CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and
elongation in synthesis of chondroitin sulfate.";
J. Biol. Chem. 278:3063-3071(2003).
[9]
FUNCTION.
PubMed=17145758; DOI=10.1074/jbc.M606870200;
Sakai K., Kimata K., Sato T., Gotoh M., Narimatsu H., Shinomiya K.,
Watanabe H.;
"Chondroitin sulfate N-acetylgalactosaminyltransferase-1 plays a
critical role in chondroitin sulfate synthesis in cartilage.";
J. Biol. Chem. 282:4152-4161(2007).
[10]
VARIANTS ARG-234 AND ARG-509, CHARACTERIZATION OF VARIANTS ARG-234 AND
ARG-509, FUNCTION, AND CATALYTIC ACTIVITY.
PubMed=21160489; DOI=10.1038/jhg.2010.148;
Saigoh K., Izumikawa T., Koike T., Shimizu J., Kitagawa H.,
Kusunoki S.;
"Chondroitin beta-1,4-N-acetylgalactosaminyltransferase-1 missense
mutations are associated with neuropathies.";
J. Hum. Genet. 56:143-146(2011).
[11]
INVOLVEMENT IN DISEASE, VARIANT ARG-384, CHARACTERIZATION OF VARIANT
ARG-384, FUNCTION, AND CATALYTIC ACTIVITY.
PubMed=27599773; DOI=10.1002/humu.23070;
Vodopiutz J., Mizumoto S., Lausch E., Rossi A., Unger S., Janocha N.,
Costantini R., Seidl R., Greber-Platzer S., Yamada S., Mueller T.,
Jilma B., Ganger R., Superti-Furga A., Ikegawa S., Sugahara K.,
Janecke A.R.;
"Chondroitin sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1)
deficiency results in a mild skeletal dysplasia and joint laxity.";
Hum. Mutat. 38:34-38(2017).
-!- FUNCTION: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-
GalNAc to the non-reducing end of glucuronic acid (GlcUA).
Required for addition of the first GalNAc to the core
tetrasaccharide linker and for elongation of chondroitin chains.
Important role in chondroitin chain biosynthesis in cartilage
formation and subsequent endochondral ossification
(PubMed:11788602, PubMed:12163485, PubMed:12446672,
PubMed:17145758). Moreover, is involved in the metabolism of
aggrecan (By similarity). {ECO:0000250|UniProtKB:Q8BJQ9,
ECO:0000269|PubMed:11788602, ECO:0000269|PubMed:12163485,
ECO:0000269|PubMed:12446672, ECO:0000269|PubMed:17145758,
ECO:0000269|PubMed:21160489, ECO:0000269|PubMed:27599773}.
-!- CATALYTIC ACTIVITY:
Reaction=3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-
(1->4)-beta-D-Xyl)-L-seryl-[protein] + UDP-N-acetyl-alpha-D-
galactosamine = 3-O-(beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-
beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-seryl-
[protein] + H(+) + UDP; Xref=Rhea:RHEA:23464, Rhea:RHEA-
COMP:12573, Rhea:RHEA-COMP:12575, ChEBI:CHEBI:15378,
ChEBI:CHEBI:58223, ChEBI:CHEBI:67138, ChEBI:CHEBI:132093,
ChEBI:CHEBI:132105; EC=2.4.1.174;
Evidence={ECO:0000269|PubMed:21160489,
ECO:0000269|PubMed:27599773};
-!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane
{ECO:0000305|PubMed:11788602}; Single-pass type II membrane
protein {ECO:0000305|PubMed:11788602}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=3;
Name=1;
IsoId=Q8TDX6-1; Sequence=Displayed;
Name=2;
IsoId=Q8TDX6-2; Sequence=VSP_012726, VSP_012727;
Note=No experimental confirmation available.;
Name=3;
IsoId=Q8TDX6-3; Sequence=VSP_012728;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Ubiquitous, with the highest levels in
placenta, thyroid, bladder, prostate and adrenal gland. Detected
at low levels in the other tissues examined.
{ECO:0000269|PubMed:11788602, ECO:0000269|PubMed:12163485,
ECO:0000269|PubMed:12446672}.
-!- PTM: N-glycosylated. {ECO:0000269|PubMed:11788602}.
-!- SIMILARITY: Belongs to the chondroitin N-
acetylgalactosaminyltransferase family. {ECO:0000305}.
-!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
Note=Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1;
URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_477";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AB071403; BAB85992.1; -; mRNA.
EMBL; AB081516; BAC16217.1; -; mRNA.
EMBL; AY358441; AAQ88806.1; -; mRNA.
EMBL; AK002126; BAA92093.1; -; mRNA.
EMBL; AK314625; BAG37191.1; -; mRNA.
EMBL; AC090541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC090786; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC116376; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC060772; AAH60772.1; -; mRNA.
EMBL; AL157483; CAB75673.1; -; mRNA.
CCDS; CCDS6010.1; -. [Q8TDX6-1]
PIR; T46919; T46919.
RefSeq; NP_001123990.1; NM_001130518.1. [Q8TDX6-1]
RefSeq; NP_060841.5; NM_018371.4. [Q8TDX6-1]
RefSeq; XP_006716421.1; XM_006716358.2.
RefSeq; XP_006716422.1; XM_006716359.2.
RefSeq; XP_006716423.1; XM_006716360.2. [Q8TDX6-1]
RefSeq; XP_006716424.1; XM_006716361.2.
RefSeq; XP_006716425.1; XM_006716362.2.
RefSeq; XP_006716426.1; XM_006716363.1. [Q8TDX6-1]
RefSeq; XP_006716427.1; XM_006716364.3. [Q8TDX6-1]
RefSeq; XP_011542880.1; XM_011544578.1. [Q8TDX6-1]
RefSeq; XP_011542881.1; XM_011544579.1. [Q8TDX6-1]
RefSeq; XP_011542882.1; XM_011544580.1.
RefSeq; XP_011542884.1; XM_011544582.1.
RefSeq; XP_011542885.1; XM_011544583.1. [Q8TDX6-1]
RefSeq; XP_011542886.1; XM_011544584.1. [Q8TDX6-1]
RefSeq; XP_016869112.1; XM_017013623.1. [Q8TDX6-1]
RefSeq; XP_016869113.1; XM_017013624.1. [Q8TDX6-1]
RefSeq; XP_016869114.1; XM_017013625.1. [Q8TDX6-1]
RefSeq; XP_016869115.1; XM_017013626.1.
RefSeq; XP_016869116.1; XM_017013627.1. [Q8TDX6-1]
RefSeq; XP_016869117.1; XM_017013628.1. [Q8TDX6-1]
RefSeq; XP_016869118.1; XM_017013629.1. [Q8TDX6-1]
RefSeq; XP_016869119.1; XM_017013630.1.
RefSeq; XP_016869120.1; XM_017013631.1.
RefSeq; XP_016869121.1; XM_017013632.1.
RefSeq; XP_016869122.1; XM_017013633.1.
RefSeq; XP_016869123.1; XM_017013634.1.
RefSeq; XP_016869124.1; XM_017013635.1.
RefSeq; XP_016869125.1; XM_017013636.1.
RefSeq; XP_016869126.1; XM_017013637.1.
RefSeq; XP_016869127.1; XM_017013638.1. [Q8TDX6-1]
UniGene; Hs.613729; -.
UniGene; Hs.721954; -.
ProteinModelPortal; Q8TDX6; -.
BioGrid; 120904; 13.
IntAct; Q8TDX6; 2.
STRING; 9606.ENSP00000310891; -.
BindingDB; Q8TDX6; -.
ChEMBL; CHEMBL2040705; -.
CAZy; GT7; Glycosyltransferase Family 7.
iPTMnet; Q8TDX6; -.
PhosphoSitePlus; Q8TDX6; -.
BioMuta; CSGALNACT1; -.
DMDM; 308153425; -.
EPD; Q8TDX6; -.
jPOST; Q8TDX6; -.
MaxQB; Q8TDX6; -.
PaxDb; Q8TDX6; -.
PeptideAtlas; Q8TDX6; -.
PRIDE; Q8TDX6; -.
ProteomicsDB; 74361; -.
ProteomicsDB; 74362; -. [Q8TDX6-2]
ProteomicsDB; 74363; -. [Q8TDX6-3]
Ensembl; ENST00000332246; ENSP00000330805; ENSG00000147408. [Q8TDX6-1]
Ensembl; ENST00000397998; ENSP00000381084; ENSG00000147408. [Q8TDX6-3]
Ensembl; ENST00000454498; ENSP00000411816; ENSG00000147408. [Q8TDX6-1]
Ensembl; ENST00000519222; ENSP00000428216; ENSG00000147408. [Q8TDX6-3]
Ensembl; ENST00000522854; ENSP00000429809; ENSG00000147408. [Q8TDX6-1]
GeneID; 55790; -.
KEGG; hsa:55790; -.
UCSC; uc003wzg.4; human. [Q8TDX6-1]
CTD; 55790; -.
DisGeNET; 55790; -.
EuPathDB; HostDB:ENSG00000147408.14; -.
GeneCards; CSGALNACT1; -.
H-InvDB; HIX0007349; -.
HGNC; HGNC:24290; CSGALNACT1.
HPA; HPA061336; -.
MIM; 616615; gene.
neXtProt; NX_Q8TDX6; -.
OpenTargets; ENSG00000147408; -.
PharmGKB; PA162382829; -.
eggNOG; KOG3588; Eukaryota.
eggNOG; ENOG410XNYM; LUCA.
GeneTree; ENSGT00940000153626; -.
HOGENOM; HOG000230628; -.
HOVERGEN; HBG050930; -.
InParanoid; Q8TDX6; -.
KO; K00746; -.
OMA; RMCMQSK; -.
OrthoDB; 389974at2759; -.
PhylomeDB; Q8TDX6; -.
TreeFam; TF318303; -.
BioCyc; MetaCyc:HS07428-MONOMER; -.
BRENDA; 2.4.1.174; 2681.
BRENDA; 2.4.1.175; 2681.
Reactome; R-HSA-2022870; Chondroitin sulfate biosynthesis.
ChiTaRS; CSGALNACT1; human.
GeneWiki; ChGn; -.
GenomeRNAi; 55790; -.
PRO; PR:Q8TDX6; -.
Proteomes; UP000005640; Chromosome 8.
Bgee; ENSG00000147408; Expressed in 230 organ(s), highest expression level in thyroid gland.
ExpressionAtlas; Q8TDX6; baseline and differential.
Genevisible; Q8TDX6; HS.
GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
GO; GO:0030173; C:integral component of Golgi membrane; NAS:UniProtKB.
GO; GO:0005622; C:intracellular; IC:UniProtKB.
GO; GO:0008376; F:acetylgalactosaminyltransferase activity; IDA:UniProtKB.
GO; GO:0047238; F:glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
GO; GO:0015020; F:glucuronosyltransferase activity; IDA:UniProtKB.
GO; GO:0047237; F:glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
GO; GO:0046872; F:metal ion binding; NAS:UniProtKB.
GO; GO:0008955; F:peptidoglycan glycosyltransferase activity; IDA:UniProtKB.
GO; GO:0009653; P:anatomical structure morphogenesis; NAS:UniProtKB.
GO; GO:0051216; P:cartilage development; IEA:Ensembl.
GO; GO:0008283; P:cell population proliferation; NAS:UniProtKB.
GO; GO:0008037; P:cell recognition; NAS:UniProtKB.
GO; GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB.
GO; GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; ISS:UniProtKB.
GO; GO:0050653; P:chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IDA:UniProtKB.
GO; GO:0050651; P:dermatan sulfate proteoglycan biosynthetic process; ISS:UniProtKB.
GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
GO; GO:0030198; P:extracellular matrix organization; NAS:UniProtKB.
GO; GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; NAS:UniProtKB.
GO; GO:0030210; P:heparin biosynthetic process; NAS:UniProtKB.
GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
GO; GO:0030166; P:proteoglycan biosynthetic process; ISS:UniProtKB.
GO; GO:0046398; P:UDP-glucuronate metabolic process; IDA:UniProtKB.
GO; GO:0019276; P:UDP-N-acetylgalactosamine metabolic process; IDA:UniProtKB.
Gene3D; 3.90.550.10; -; 1.
InterPro; IPR008428; Chond_GalNAc.
InterPro; IPR029044; Nucleotide-diphossugar_trans.
Pfam; PF05679; CHGN; 1.
SUPFAM; SSF53448; SSF53448; 1.
1: Evidence at protein level;
Alternative splicing; Coiled coil; Complete proteome;
Disease mutation; Glycoprotein; Golgi apparatus; Membrane;
Metal-binding; Polymorphism; Reference proteome; Signal-anchor;
Transferase; Transmembrane; Transmembrane helix.
CHAIN 1 532 Chondroitin sulfate N-
acetylgalactosaminyltransferase 1.
/FTId=PRO_0000189564.
TOPO_DOM 1 14 Cytoplasmic. {ECO:0000255}.
TRANSMEM 15 35 Helical; Signal-anchor for type II
membrane protein. {ECO:0000255}.
TOPO_DOM 36 532 Lumenal. {ECO:0000255}.
COILED 57 100 {ECO:0000255}.
METAL 360 360 Divalent metal cation. {ECO:0000255}.
METAL 477 477 Divalent metal cation. {ECO:0000255}.
CARBOHYD 315 315 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 324 324 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
VAR_SEQ 1 257 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_012726.
VAR_SEQ 258 282 MANTLINVIVPLAKRVDKFRQFMQN -> MESYSVTQAGVQ
WHELCSLQPSPPR (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_012727.
VAR_SEQ 285 532 EMCIEQDGRVHLTVVYFGKEEINEVKGILENTSKAANFRNF
TFIQLNGEFSRGKGLDVGARFWKGSNVLLFFCDVDIYFTSE
FLNTCRLNTQPGKKVFYPVLFSQYNPGIIYGHHDAVPPLEQ
QLVIKKETGFWRDFGFGMTCQYRSDFINIGGFDLDIKGWGG
EDVHLYRKYLHSNLIVVRTPVRGLFHLWHEKRCMDELTPEQ
YKMCMQSKAMNEASHGQLGMLVFRHEIEAHLRKQKQKTSSK
KT -> PADEVFRCVPLSP (in isoform 3).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_012728.
VARIANT 137 137 V -> I (in dbSNP:rs17128518).
/FTId=VAR_055647.
VARIANT 193 193 S -> N (in dbSNP:rs7017776).
{ECO:0000269|PubMed:11788602,
ECO:0000269|PubMed:12163485,
ECO:0000269|PubMed:12975309,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:17974005}.
/FTId=VAR_060391.
VARIANT 234 234 H -> R (found in a patient with
neuropathy; unknown pathological
significance; loss of GalNAc-transferase
activity; no effect on protein
expression; dbSNP:rs200092345).
{ECO:0000269|PubMed:21160489}.
/FTId=VAR_078123.
VARIANT 384 384 P -> R (probable disease-associated
mutation found in a patient with a mild
skeletal dysplasia with shortness of long
bones of prenatal onset; loss of GalNAc-
transferase activity; dbSNP:rs746391651).
{ECO:0000269|PubMed:27599773}.
/FTId=VAR_078124.
VARIANT 473 473 F -> Y (in dbSNP:rs17128366).
/FTId=VAR_055648.
VARIANT 509 509 M -> R (found in a patient with
neuropathy; unknown pathological
significance; loss of GalNAc-transferase
activity; no effect on protein
expression; dbSNP:rs533235539).
{ECO:0000269|PubMed:21160489}.
/FTId=VAR_078125.
CONFLICT 246 246 G -> S (in Ref. 1; BAB85992 and 3;
AAQ88806). {ECO:0000305}.
CONFLICT 252 252 K -> E (in Ref. 6; AAH60772).
{ECO:0000305}.
CONFLICT 312 312 I -> V (in Ref. 4; BAA92093).
{ECO:0000305}.
SEQUENCE 532 AA; 61294 MW; DB76B0FD6D74FD82 CRC64;
MMMVRRGLLA WISRVVVLLV LLCCAISVLY MLACTPKGDE EQLALPRANS PTGKEGYQAV
LQEWEEQHRN YVSSLKRQIA QLKEELQERS EQLRNGQYQA SDAAGLGLDR SPPEKTQADL
LAFLHSQVDK AEVNAGVKLA TEYAAVPFDS FTLQKVYQLE TGLTRHPEEK PVRKDKRDEL
VEAIESALET LNSPAENSPN HRPYTASDFI EGIYRTERDK GTLYELTFKG DHKHEFKRLI
LFRPFGPIMK VKNEKLNMAN TLINVIVPLA KRVDKFRQFM QNFREMCIEQ DGRVHLTVVY
FGKEEINEVK GILENTSKAA NFRNFTFIQL NGEFSRGKGL DVGARFWKGS NVLLFFCDVD
IYFTSEFLNT CRLNTQPGKK VFYPVLFSQY NPGIIYGHHD AVPPLEQQLV IKKETGFWRD
FGFGMTCQYR SDFINIGGFD LDIKGWGGED VHLYRKYLHS NLIVVRTPVR GLFHLWHEKR
CMDELTPEQY KMCMQSKAMN EASHGQLGML VFRHEIEAHL RKQKQKTSSK KT
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur
GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur
Pathways :
WP1367: TGF-beta Receptor Signaling Pathway
WP1982: SREBP signalling
WP580: Dauer formation
WP100: Glutathione metabolism
WP1016: Wnt Signaling Pathway
WP1039: Glutathione metabolism
WP104: Alanine and aspartate metabolism
WP1045: TGF-beta Receptor Signaling Pathway
WP1048: TGF Beta Signaling Pathway
WP105: Fatty Acid Beta Oxidation 2
WP1056: Complement and Coagulation Cascades
WP1058: Senescence and Autophagy
WP106: Alanine and aspartate metabolism
WP1061: Fatty Acid Beta Oxidation
WP1106: Keap1-Nrf2
WP1107: Mitochondrial LC-Fatty Acid Beta-Oxidation
WP1126: Tryptophan metabolism
WP113: TGF Beta Signaling Pathway
WP1135: Wnt Signaling Pathway
WP1161: TGF-beta Receptor Signaling Pathway
WP1164: TGF Beta Signaling Pathway
WP1172: Complement and Coagulation Cascades
WP1177: Fatty Acid Beta Oxidation
WP1207: Fatty Acid Beta Oxidation
WP1224: EBV LMP1 signaling
Related Genes :
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits